200 selly park road, selly park, birmingham, B29 7HY
Website
-
birmingham endocrine care limitedEstimated Valuation
£9.9k
Pomanda estimates the enterprise value of BIRMINGHAM ENDOCRINE CARE LIMITED at £9.9k based on a Turnover of £23.1k and 0.43x industry multiple (adjusted for size and gross margin).
birmingham endocrine care limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BIRMINGHAM ENDOCRINE CARE LIMITED at £0 based on an EBITDA of £-4.6k and a 2.91x industry multiple (adjusted for size and gross margin).
birmingham endocrine care limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BIRMINGHAM ENDOCRINE CARE LIMITED at £0 based on Net Assets of £-11k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Birmingham Endocrine Care LimitedOverview
Birmingham Endocrine Care Limited is a dissolved company that was located in birmingham, B29 7HY with a Companies House number of 10421022. It operated in the specialists medical practice activities sector, SIC Code 86220. Founded in October 2016, it's largest shareholder was
sumitra ghosh
with a 50% stake. The last turnover for Birmingham Endocrine Care Limited was estimated at £23.1k.
Pomanda's financial health check has awarded Birmingham Endocrine Care Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
3 Strong
1 Regular
6 Weak
Size
annual sales of £23.1k, make it smaller than the average company (£415.7k)
£23.1k - Birmingham Endocrine Care Limited
£415.7k - Industry AVG
Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (1.9%)
35% - Birmingham Endocrine Care Limited
1.9% - Industry AVG
Production
with a gross margin of 36.6%, this company has a higher cost of product (57.6%)
36.6% - Birmingham Endocrine Care Limited
57.6% - Industry AVG
Profitability
an operating margin of -20% make it less profitable than the average company (14.7%)
-20% - Birmingham Endocrine Care Limited
14.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (14)
1 - Birmingham Endocrine Care Limited
14 - Industry AVG
Pay Structure
on an average salary of £27.2k, the company has an equivalent pay structure (£27.2k)
£27.2k - Birmingham Endocrine Care Limited
£27.2k - Industry AVG
Efficiency
resulting in sales per employee of £23.1k, this is less efficient (£69.7k)
£23.1k - Birmingham Endocrine Care Limited
£69.7k - Industry AVG
Debtor Days
it gets paid by customers after 4 days, this is earlier than average (40 days)
4 days - Birmingham Endocrine Care Limited
40 days - Industry AVG
Creditor Days
its suppliers are paid after 285 days, this is slower than average (34 days)
285 days - Birmingham Endocrine Care Limited
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Birmingham Endocrine Care Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Birmingham Endocrine Care Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2204%, this is a higher level of debt than the average (33.8%)
2204% - Birmingham Endocrine Care Limited
33.8% - Industry AVG
BIRMINGHAM ENDOCRINE CARE LIMITED financials
EXPORT
Birmingham Endocrine Care Limited's latest turnover from October 2021 is estimated at £23.1 thousand and the company has net assets of -£11 thousand. According to their latest financial statements, Birmingham Endocrine Care Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Oct 2021
Oct 2020
Oct 2019
Oct 2018
Oct 2017
Turnover
23,132
25,078
41,238
9,473
7,662
Other Income Or Grants
Cost Of Sales
14,677
16,855
25,766
5,594
4,215
Gross Profit
8,455
8,222
15,472
3,879
3,447
Admin Expenses
13,073
12,167
12,577
8,775
3,259
Operating Profit
-4,618
-3,945
2,895
-4,896
188
Interest Payable
Interest Receivable
Pre-Tax Profit
-4,618
-3,945
2,895
-4,896
188
Tax
-550
-36
Profit After Tax
-4,618
-3,945
2,345
-4,896
152
Dividends Paid
Retained Profit
-4,618
-3,945
2,345
-4,896
152
Employee Costs
27,187
24,426
26,530
26,318
26,726
Number Of Employees
1
1
1
1
1
EBITDA*
-4,618
-3,945
2,895
-4,896
188
* Earnings Before Interest, Tax, Depreciation and Amortisation
Oct 2021
Oct 2020
Oct 2019
Oct 2018
Oct 2017
Tangible Assets
218
291
388
517
689
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
218
291
388
517
689
Stock & work in progress
Trade Debtors
303
2,109
10,378
2,246
2,231
Group Debtors
Misc Debtors
Cash
misc current assets
total current assets
303
2,109
10,378
2,246
2,231
total assets
521
2,400
10,766
2,763
2,920
Bank overdraft
Bank loan
Trade Creditors
11,483
8,744
13,165
7,507
2,768
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
11,483
8,744
13,165
7,507
2,768
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
11,483
8,744
13,165
7,507
2,768
net assets
-10,962
-6,344
-2,399
-4,744
152
total shareholders funds
-10,962
-6,344
-2,399
-4,744
152
Oct 2021
Oct 2020
Oct 2019
Oct 2018
Oct 2017
Operating Activities
Operating Profit
-4,618
-3,945
2,895
-4,896
188
Depreciation
Amortisation
Tax
-550
-36
Stock
Debtors
-1,806
-8,269
8,132
15
2,231
Creditors
2,739
-4,421
5,658
4,739
2,768
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
-73
-97
-129
-172
689
Investing Activities
capital expenditure
73
97
129
172
-689
Change in Investments
cash flow from investments
73
97
129
172
-689
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest
cash flow from financing
cash and cash equivalents
cash
overdraft
change in cash
birmingham endocrine care limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for birmingham endocrine care limited. Get real-time insights into birmingham endocrine care limited's credit score, group structure and payment trends.
Birmingham Endocrine Care Limited Competitor Analysis
Perform a competitor analysis for birmingham endocrine care limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in B29 area or any other competitors across 12 key performance metrics.
birmingham endocrine care limited Ownership
BIRMINGHAM ENDOCRINE CARE LIMITED group structure
Birmingham Endocrine Care Limited has no subsidiary companies.
Ultimate parent company
BIRMINGHAM ENDOCRINE CARE LIMITED
10421022
BIRMINGHAM ENDOCRINE CARE LIMITED Shareholders
The largest shareholders in Birmingham Endocrine Care Limited include Sumitra Ghosh and Dr Sandip Ghosh.
sumitra ghosh
50%
dr sandip ghosh
50%
birmingham endocrine care limited directors
Birmingham Endocrine Care Limited currently has 1 director, Dr Sandip Ghosh serving since Oct 2016.
200 selly park road, selly park, birmingham, B29 7HY
Bank
-
Legal Advisor
-
birmingham endocrine care limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to birmingham endocrine care limited.
birmingham endocrine care limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIRMINGHAM ENDOCRINE CARE LIMITED. This can take several minutes, an email will notify you when this has completed.
birmingham endocrine care limitedCompanies House Filings - See Documents
